Table 2.
Adverse events | Duloxetine | Amitriptyline | P |
---|---|---|---|
Somnolence | 18 (31) | 21 (36) | 0.89 |
Dry mouth | 14 (24) | 32 (55) | <0.001 |
Constipation | 22 (37) | 10 (17) | 0.06 |
Lethargy | 14 (24) | 19 (33) | 0.30 |
Insomnia | 9 (15) | 6 (10) | 0.71 |
Uneasiness | 11 (19) | 6 (10) | 0.40 |
Dizziness | 7 (12) | 8 (14) | 0.86 |
Nausea | 6 (10) | 3 (5) | 0.58 |
Anorexia | 5 (8) | 1 (2) | 0.25 |
Headache | 4 (7) | 3 (5) | 0.78 |
Pain abdomen | 1 (2) | 1 (2) | 0.95 |
Itching | 1 (2) | 1 (2) | 0.95 |
Total adverse events (n) | 112 | 111 | |
Mild events* | 98 | 82 | <0.02 |
Moderate to severe events† | 14 | 29 | <0.01 |
Data are n (%). n = 58 in each group.
*Mild: not requiring any intervention or discontinuation.
†Moderate to severe: limiting dose uptitration, requiring intervention or discontinuation of the drug.